Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by Nohandledzepon Mar 28, 2012 11:21am
321 Views
Post# 19727741

RE: VMC .. nohanndlezep

RE: VMC .. nohanndlezep

Silvarline...I think I have a pretty good handle on BNC by now. I have listened to conference calls and attended more than one AGM and certainly I am well aware of the waterlogged stock price.

 

However, I do not share your sunny disposition on the success of the management team, nor do most, as the share price trajectory of the last several years would indicate. With that said I am not a seller and do believe that the company is significantly undervalued. That fact/problem/dilemna is not the fault of their fringe retail shareholders or the market.

 

BNC has been a TSX doormat for years, through bull and bear markets and it appears that no one beyond their "Fringe Retail Shareholders"/ all their retail shareholders  believes otherwise.

 

Yes I thought both of last weeks releases were positive, but apparently most did not. I would say the reaction was neutral at best.

 

For the record, this is not 11 mil in new revenue. Its an 11 mil market where they may capture 25% if they are fortunate.

Bullboard Posts